StreetInsider.com News Articles

McKesson (MCK) Declares $0.94 Quarterly Dividend; 0.4% Yield

Wed, 21 Oct 2026 08:00:16 -0400

McKesson (NYSE: MCK) declared a quarterly dividend of $0.94 per share, or $3.76 annualized.

The dividend will be payable on January 4, 2027, to stockholders of record on December 1, 2026, with an ex-dividend date of November 30, 2026.

The annual yield on the dividend is 0.4 percent.

For a dividend history and other dividend-related data on McKesson (MCK) click here.

McKesson Corporation Declares Quarterly Dividend

Wed, 21 Oct 2026 08:00:00 -0400

IRVING, Texas--(BUSINESS WIRE)-- The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of 94 cents per share of common stock. The dividend will be payable on January 4, 2027, to shareholders of record on December 1, 2026.

About McKesson Corporation

McKesson Corporation is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products and services to help make quality care more accessible and affordable. Learn more about how McKesson is impacting virtually every aspect of

McKesson Corporation Declares Quarterly Dividend

Wed, 21 Oct 2026 08:00:00 -0400

About McKesson Corporation

McKesson (MCK) PT Raised to $1,020 at Mizuho

Tue, 20 Oct 2026 06:37:22 -0400

Mizuho analyst Steven Valiquette raised the price target on McKesson (NYSE: MCK) to $1,020.00 (from $950.00) while maintaining a Neutral rating.

Form 4 MCKESSON CORP For: Oct 15 Filed by: Fraga Francisco

Mon, 19 Oct 2026 16:40:00 -0400

si-local-file:///var/storage/secattach/20261019/27204438.html

McKesson (MCK) PT Raised to $1,200 at UBS

Fri, 16 Oct 2026 09:14:30 -0400

UBS analyst Kevin Caliendo raised the price target on McKesson (NYSE: MCK) to $1,200.00 (from $1,080.00) while maintaining a Buy rating.

Form 144 MCKESSON CORP Filed by: Fraga Francisco

Thu, 15 Oct 2026 10:33:00 -0400

si-local-file:///var/storage/secattach/20261015/27191667.html

McKesson (MCK) PT Raised to $1,017 at Baird

Mon, 12 Oct 2026 07:22:39 -0400

Baird analyst Eric Coldwell raised the price target on McKesson (NYSE: MCK) to $1,017.00 (from $1,015.00) while maintaining a Outperform rating.

Form 8-K MCKESSON CORP For: Oct 06

Tue, 06 Oct 2026 08:04:00 -0400

si-local-file:///var/storage/secattach/20261006/27152268.html

CD&R and McKesson to acquire Option Care Health for $5.8B

Tue, 06 Oct 2026 08:00:42 -0400

CD&R and McKesson Corporation (NYSE: MCK) have signed a definitive agreement to acquire Option Care Health, Inc. (Nasdaq: OPCH), a home and alternate site infusion services provider, for $32.05 per share, representing a total enterprise value of approximately $5.8 billion.

Under the terms of the deal, CD&R will hold a majority interest of approximately 51%, while McKesson will invest approximately $1.4 billion for a minority interest of approximately 49%. Option Care Health will continue to operate as a separate company under its existing management team.

The offer price represents a premium of approximately 37% to Option Care Health's closing share price on

CD&R and McKesson to acquire Option Care Health for $5.8B

Tue, 06 Oct 2026 08:00:42 -0400

The offer price represents a premium of approximately 37% to Option Care Health's closing share price on

CD&R and McKesson Corporation Sign Agreement to Acquire Option Care Health

Tue, 06 Oct 2026 08:00:00 -0400

NEW YORK & IRVING, Texas & BANNOCKBURN, Ill.--(BUSINESS WIRE)-- CD&R, McKesson Corporation (NYSE: MCK) (“McKesson”), and Option Care Health, Inc. (Nasdaq: OPCH) (“Option Care Health”) announced today that they have entered into a definitive agreement, under which CD&R and McKesson will acquire Option Care Health, an independent provider of home and alternate site infusion services, for $32.05 per share, reflecting a total enterprise value of approximately $5.8 billion. At the closing of the transaction, CD&R will hold a majority ownership interest, and McKesson will hold a minority ownership interest. Option Care Health will remain a separate company

CD&R and McKesson Corporation Sign Agreement to Acquire Option Care Health

Tue, 06 Oct 2026 08:00:00 -0400

CD&R and McKesson Corporation Sign Agreement to Acquire Option Care Health

Tue, 06 Oct 2026 08:00:00 -0400

CD&R and McKesson Corporation Sign Agreement to Acquire Option Care Health

Tue, 06 Oct 2026 08:00:00 -0400

Option Care Health surges 22% on report of $5 billion takeover by McKesson, CD&R

Mon, 05 Oct 2026 16:31:14 -0400

Investing.com -- Shares of Option Care Health (NASDAQ: OPCH) surged 22% in after-hours trading on Monday following a Financial Times report that healthcare giant McKesson and private equity firm Clayton Dubilier & Rice (CD&R) are in advanced talks to acquire the infusion services provider. The potential transaction is expected to value the company at more than $5 billion, including debt.

Citing people familiar with the matter, the report noted that an agreement could be reached as soon as Tuesday, though negotiations are ongoing and could still fall apart.

Under the proposed terms, CD&R

Option Care Health surges 22% on report of $5 billion takeover by McKesson, CD&R

Mon, 05 Oct 2026 16:31:14 -0400

Citing people familiar with the matter, the report noted that an agreement could be reached as soon as Tuesday, though negotiations are ongoing and could still fall apart.

Under the proposed terms, CD&R

Option Care Health surges 22% on report of $5 billion takeover by McKesson, CD&R

Mon, 05 Oct 2026 16:31:14 -0400

Citing people familiar with the matter, the report noted that an agreement could be reached as soon as Tuesday, though negotiations are ongoing and could still fall apart.

Under the proposed terms, CD&R

Option Care Health surges 22% on report of $5 billion takeover by McKesson, CD&R

Mon, 05 Oct 2026 16:31:14 -0400

Citing people familiar with the matter, the report noted that an agreement could be reached as soon as Tuesday, though negotiations are ongoing and could still fall apart.

Under the proposed terms, CD&R

McKesson extends CVS deal; shares rise

Thu, 01 Oct 2026 13:32:54 -0400

Investing.com -- McKesson Corporation (NYSE:MCK) shares rose 4.4% Thursday following the announcement of an extended pharmaceutical distribution agreement with CVS Health through June 2032.

The healthcare services company signed an agreement in principle to continue distributing pharmaceuticals to CVS Health's mail order and specialty pharmacies, retail pharmacies, and distribution centers. The partnership between the two companies has existed for more than 25 years.

"We are pleased to extend our long-standing, strategic relationship with CVS Health and continue supporting their important role in serving patients and communities across the country," commented Brian Tyler, chair and chief executive officer of McKesson.

McKesson extends CVS Health pharma distribution deal through 2032

Thu, 01 Oct 2026 08:03:44 -0400

McKesson Corporation (NYSE: MCK) has signed an agreement in principle to extend its pharmaceutical distribution partnership with CVS Health through June 2032, covering mail order and specialty pharmacies, retail pharmacies, and distribution centers.

Brian Tyler, chair and chief executive officer of McKesson, said in a statement: "We are pleased to extend our long-standing, strategic relationship with CVS Health and continue supporting their important role in serving patients and communities across the country."

McKesson also reaffirmed its fiscal year 2027 adjusted earnings per share guidance of $44.20 to $45.00, along with a long-term adjusted EPS growth rate of 13% to 16%. The company

McKesson extends CVS Health pharma distribution deal through 2032

Thu, 01 Oct 2026 08:03:44 -0400

McKesson also reaffirmed its fiscal year 2027 adjusted earnings per share guidance of $44.20 to $45.00, along with a long-term adjusted EPS growth rate of 13% to 16%. The company

McKesson Corporation Extends Pharmaceutical Distribution Agreement with CVS Health

Thu, 01 Oct 2026 08:03:00 -0400

IRVING, Texas--(BUSINESS WIRE)-- McKesson Corporation (NYSE: MCK) announced today that it has signed an agreement in principle to extend its partnership with CVS Health to distribute pharmaceuticals to mail order and specialty pharmacies, retail pharmacies, and distribution centers through June 2032.

“We are pleased to extend our long-standing, strategic relationship with CVS Health and continue supporting their important role in serving patients and communities across the country,” said Brian Tyler, chair and chief executive officer of McKesson. “For more than 25 years, our teams have worked together to deliver reliable, high-quality services to patients, and we remain committed

McKesson Corporation Extends Pharmaceutical Distribution Agreement with CVS Health

Thu, 01 Oct 2026 08:03:00 -0400

McKesson Corporation Announces Second Quarter Fiscal 2027 Earnings Release Date

Wed, 23 Sep 2026 08:00:00 -0400

IRVING, Texas--(BUSINESS WIRE)-- McKesson Corporation (NYSE: MCK) will release its second quarter fiscal 2027 financial results after market close on Wednesday, November 4, 2026. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results.

The live and archived audio webcast will be available on McKesson’s Investor Relations website.

About McKesson Corporation